Navigation Links
Toward a safer form of acetaminophen
Date:7/10/2013

Efforts to develop a safer form of acetaminophen the pain and fever-reducer that is one of the most widely used drugs have led to discovery of substances that may have less potentially toxic effects on the liver. A report on the research appears in ACS Medicinal Chemistry Letters.

Roman Shchepin and colleagues explain that a link exists between acetaminophen and liver damage. The damage may be severe and can occur with intentional and accidental overdoses, as well as when susceptible individuals take the drug. Indeed, acetaminophen has been implicated in almost 50 percent of all acute liver failure cases in the United States alone. Scientists have known the biochemical basis of acetaminophen's liver toxicity, and Shchepin and colleagues set out to develop safer versions of acetaminophen.

They describe the design and testing of two compounds that have a similar architecture to acetaminophen, but aren't toxic to liver cells grown in the laboratory. The researchers say that, although further testing is needed, these compounds are promising candidates for acetaminophen replacements.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. New materials, progress toward an HIV vaccine, and more at meeting of crystallographers
2. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
3. Toward broad-spectrum antiviral drugs for common cold and other infections
4. NREL drives toward the future with fuel cell EVs
5. Engineered stem cell advance points toward treatment for ALS
6. A giant step toward miniaturization
7. The large-scale EU project EU BON: Towards integration with its global counterpart GEO BON
8. Towards more sustainable construction
9. Report: Water and Agriculture in Canada: Towards Sustainable Management of Water Resources
10. Fat worms inch scientists toward better biofuel production
11. BESAFE Conference in Manchester: Working towards a brighter future for biodiversity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2019)... (PRWEB) , ... January 23, 2019 , ... ... that it has received a Notice of Allowance from the United States Patent ... filed by its affiliate company, DNA Medicine Institute (DMI). This application covers the ...
(Date:1/20/2019)... ... January 16, 2019 , ... uBiome, the leader ... platform that uses artificial intelligence (AI) and a data-centric approach to decentralize medicine ... ulcerative colitis. , People will Crohn’s or other chronic medical conditions join a ...
(Date:1/20/2019)... ... January 18, 2019 , ... Boston-based Laboratory as a Service ... an effort to better express its continued expansion and service offerings for biotech and ... new kind of lab: one that is more agile and adaptable than ever before. ...
Breaking Biology News(10 mins):
(Date:1/11/2019)... ... 11, 2019 , ... Drawing on over 22 years of software development expertise, ... EST will explore some of the key lessons that have driven customer satisfaction with ... multiple vendors, and find out how to ensure that you continue to be able ...
(Date:1/10/2019)... ... January 08, 2019 , ... ... spinal implant company, announced today that SAGICO will be represented at the ... annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare ...
(Date:1/8/2019)... (PRWEB) , ... January 07, 2019 , ... ... of its members into Noninvasix. This represents the second investment AngelMD has made ... mortality and morbidity, Noninvasix is developing a patient monitor to directly, accurately, and ...
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine Inc. today ... drug candidate, code-named "KM-819." KM-819 is an orally active small molecule that ... South Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation study was ...
Breaking Biology Technology: